NOVARTINDBSENovartis India Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 19 Jun, 2026 · 07:58 IST

Novartis India Open Offer Update - Equity Shares Tendered Disclosure Filed

Open Offer TriggeredStrategic Transactions View source PDFExplain this filing

NOVARTIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.7%Reaction day
₹1369.40
prior close
₹1371.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+0.8% vs market
Pharmaceuticals peers, median of 160sector+0.4%+1.2% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-1.0
15m
-0.6
30m
+1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.7+0.8+0.8+0.4+1.2
Next day
+9.5+1.7+7.9+0.5+9.0
2d
+8.1+0.9+7.2+1.7+6.5
3d
+7.7+0.8+6.9+1.7+6.0
4d
+4.5+0.2+4.3+0.9+3.6
5d
+5.5-0.1+5.6+1.5+4.0
1w
+5.9+1.1+4.7+2.7+3.2
15d
+23.2+2.5+20.6+4.1+19.1
1m
+22.0+1.2+20.8+4.0+18.0
2m
+12.3+4.9+7.3+2.0+10.3
3m
+46.7+5.8+40.9+7.7+39.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Axis Capital Ltd, acting as Manager to the Open Offer for Novartis India, has filed a disclosure with BSE detailing the number of equity shares tendered by public shareholders in the ongoing open offer. This is a routine update under SEBI takeover regulations, reflecting how many shares have been offered by shareholders in response to the open offer. The exact tendered quantity would be available in the detailed disclosure submitted to the exchange.

Likely market impact

Informs shareholders about tendering response in the open offer. Higher tendering indicates strong acceptance and may shift shareholding and control of Novartis India.